India's Caplin Point Laboratories hits record high on pact with Tamil Nadu govt
** Shares of pharma co Caplin Point Laboratories CAPL.NS
rise as much as 5.8% to 1,470 rupees, hitting a record high;
last up 2%
** Caplin group signs memorandum of understanding with Tamil
Nadu government for investment of 7 billion rupees ($84.24
million) in various projects for 5 years
** Stock trading above its 50-, 100-, and 200-day moving
averages since Nov
** More than 240,000 shares change hands, 1.8x the 30-day
avg
** Stock gained about 90% in 2023, best year since 2015
($1 = 83.0950 Indian rupees)
(Reporting by Dimpal Gulwani in Bengaluru)
((dimpal.gulwani@thomsonreuters.com))
Recent news on Caplin Point Laboratories
See all newsBrief: Caplin Point Laboratories Says US FDA Completes Unannounced Inspection Of Caplin Steriles Gummidipoondi Facility
Brief: Caplin Point Laboratories March-Quarter Consol Net Profit 1.7 Bln Rupees
Brief: Caplin Point Laboratories Unit Receives Final USFDA Approval For ANDA Potassium Phosphates Injection
Brief: Caplin Point Laboratories Says Unit Receives USFDA Approval For Sodium Phosphates Injection
Brief: Caplin Point Laboratories Dec-Quarter Consol Net Profit 1.64 Billion Rupees